ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-05-18		NCT03587740

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dana-Farber Cancer Institute	324
Gateway for Cancer Research	32
Susan G. Komen Breast Cancer Foundation	16

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Comprehensive Cancer Center	Duarte	United States	263
Dana Farber Cancer Institute	Boston	United States	300
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center	Brighton	United States	2
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center	Milford	United States	4
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital	South Weymouth	United States	3
Dana-Farber/New Hampshire Oncology-Hematology	Londonderry	United States	4
Lifespan Cancer Institute	Providence	United States	13
Massachusetts General Hospital	Boston	United States	12
Mayo Clinic	Rochester	United States	664
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Rex Cancer Center	Raleigh	United States	8
Sarah Cannon Research Institute	Nashville	United States	119
The Stamford Hospital	Stamford	United States	2
University of North Carolina	Chapel Hill	United States	101